Serum oxidized albumin and cardiovascular mortality in normoalbuminemic hemodialysis patients: a cohort study
Autor: | Chan Hsu Chen, Yuan-Chuan Kuo, Yachung Jeng, Ming Ying Wu, Chia-San Liu, Shiaw-Wen Chien, Mei-Ann Pai, Paik Seong Lim, Hung Ping Chen, Tsai-Kun Wu |
---|---|
Rok vydání: | 2013 |
Předmět: |
Male
Epidemiology medicine.medical_treatment lcsh:Medicine Cardiovascular Gastroenterology Biochemistry Cohort Studies Chronic Kidney Disease Clinical Epidemiology lcsh:Science Child Multidisciplinary biology Mortality rate Middle Aged Human serum albumin Cardiovascular Diseases Nephrology Child Preschool Cohort Blood Chemistry Medicine Female Hemodialysis Oxidation-Reduction medicine.drug Cohort study Research Article Adult medicine.medical_specialty Adolescent Clinical Research Design Serum albumin Young Adult Renal Dialysis Internal medicine medicine Humans Biology Serum Albumin Cardiovascular Disease Epidemiology Aged Proportional Hazards Models Retrospective Studies Plasma Proteins business.industry lcsh:R Albumin Infant Proteins Retrospective cohort study Oxidative Stress Immunology biology.protein lcsh:Q business Dialysis |
Zdroj: | PLoS ONE PLoS ONE, Vol 8, Iss 7, p e70822 (2013) |
ISSN: | 1932-6203 |
Popis: | Background Substantial evidence suggests that increased oxidative stress in hemodialysis (HD) patients may contribute to cardiovascular complications. Oxidative modifications of human serum albumin (HSA), the largest thiol pool in plasma, alter its biological properties and may affect its antioxidant potential in HD patients. Methods We conducted a long-term follow-up study in a cohort of normoalbuminemic HD patients to examine the impact of redox state of serum albumin on patients’ survival by measuring the human nonmercaptoalbumin (HNA) fraction of HSA. Results After adjusting for potential demographic, anthropometric, and clinical confounders, a positive association of HNA level with the risk of death from cardiovascular disease (CVD) and all-cause mortality was observed in normoalbuminemic HD patients. Using stratified analysis, we found a stronger association between HNA level and the risk of death from CVD and all-cause mortality in patients with pre-existing CVD. Conclusions Serum HNA level is a positive predictor of mortality in normoalbuminemic HD patients, especially among those with pre-existing CVD. Increased oxidative stress resulting from biological changes in serum albumin levels could contribute to accelerated atherosclerosis and the development of cardiovascular disease in HD patients. |
Databáze: | OpenAIRE |
Externí odkaz: |